Skip to content

ACRYSOF® SN6AT4 (REF SN6AT4.195)Recalls & reported problems

Alcon Laboratories, Inc. · AcrySof(R) IQ TORIC ASTIGMATISM IOL, SINGLE-PIECE ACRYLIC FOLDABLE LENS, UV WITH BLUE LIGHTFILTER, 13.0mm LENGTH, 6.0mm BICONVEX TORICASPHERIC OPTIC, 2.25 D CYLINDER. · Class 3 · Implant

All models of ACRYSOF (353)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
5
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00380652250412), received between Apr 3, 2024 and Apr 18, 2025 — classified as 2 injuries, 3 malfunctions.

The most frequently reported specific device problem is “Break” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 1 reportsMay 2024: 1 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 2 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 1 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Break1
  • Defective Device1
  • Failure to Deliver1
  • Material Discolored1

Patient problems

  • Insufficient Information3
  • Blurred Vision1
  • Posterior Capsule Opacification1
  • Retinal Detachment1
  • Visual Disturbances1

Recent adverse event reports

The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.

  • MalfunctionApr 18, 2025Failure to Deliver; Failure to Deliver

    A PHARMACIST REPORTED THAT LENS FOUND TO BE BLOCKED. THE SECOND LENS WAS USED IN THE PATIENT AND DID NOT EXPERIENCE ANY DISCOMFORT. ADDITIONAL INFORMATION HAS BEEN REQUESTED HOWEVER NO FURTHER INFORMATION RECEIVED.

    Patient problems: Insufficient Information

    MAUDE report 21866072 ↗
  • InjurySep 27, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A CONSUMER REPORTED ABOUT A COMPANY LENS TRANSPLANT DONE SEVERAL YEARS AGO. DURING FOLLOW-UP EXAM, WAS IN A LOT OF PAIN DURING THE SURGERY. THE DR. STATED HE HAD PROBLEMS DURING SURGERY. WHEN HE INSTALLED THE LENS IT WENT IN UPSIDE DOWN AND THEY HAD TO CUT IT OUT AND PUT ANOTHER ONE IN. THE PROBLEM WAS DURING AN EYE EXAM ( DIFFERENT DRS.) BOTH EYES WERE 20/20, BUT THE COMPANY LENS IMPLANTED EYE SEES THINGS CLOSER AND A LITTLE LOWER THAN THE EYE WITH A STANDARD LENS CONSUMER REPORTED A VISION DEPTH PROBLEM. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

    Patient problems: Blurred Vision; Visual Disturbances

    MAUDE report 20322977 ↗
  • InjurySep 13, 2024Material Discolored; Material Discolored

    A OTHER HEALTH CARE PROFESSIONAL REPORTED THAT AFTER SURGERY, THE PATIENT EXPERIENCED SEVERE POSTERIOR CAPSULAR OPACIFICATION AND HAD A YAG LASER TREATMENT BEFORE TO REMOVE PCO. PATIENT HAS DEVELOPED CANCER AND IS ALSO NOW ON CANCER TREATMENT. ADDITIONAL INFORMATION HAS BEEN REQUESTED. THERE ARE TWO MEDICAL REPORTS ASSOCIATED WITH THIS PATIENT. THIS FILE BELONGS TO RIGHT EYE. ADDITIONAL INFORMATION HAS RECEIVED IT STATES THAT THE PATIENT¿S VISION WAS GOOD, CORRECTED TO 1.2 IN RIGHT EYE. IN 2017, NOTICED THE GRADUAL ONSET SYMPTOMS OF PCO. AFTER YAG LASER TREATMENT, VISION WAS IMPROVED FROM 0.4 TO 1.0 IN THE RIGHT EYE, VISION CLEARED UP AND WAS GOOD. IN 2019 DURING EXAMINATION OF PCO RECURRENCE THEY NOTICED SLIGHT YELLOWING OF IOL, POSSIBLE OPACIFICATION STARTING. IN 2022, ALSO HAD A SAME FINDING. SO, THEY HAVE PLANNED A SURGERY FOR THE PATIENT.

    Patient problems: Posterior Capsule Opacification; Retinal Detachment

    MAUDE report 20213120 ↗
  • MalfunctionMay 20, 2024Defective Device; Defective Device

    A HEALTH CARE PROFESSIONAL REPORTED THAT THEY NOTICED THAT LENS WERE DEFECTIVE. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

    Patient problems: Insufficient Information

    MAUDE report 19353118 ↗
  • MalfunctionApr 3, 2024Break; Break

    A HEALTH CARE PROFESSIONAL REPORTED DURING INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE LENS BROKEN WHEN INJECTED IN PATIENT EYE. THE LENS HAD TO CUT TO REMOVE IT FROM THE PATIENT¿S EYE DURING INITIAL PROCEDURE. ADDITIONAL INFORMATION HAS BEEN REQUESTED.

    Patient problems: Insufficient Information

    MAUDE report 19030819 ↗

Other intraocular lens devices

All intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page